GLP-1 Peptide★ 4.8
Cagrilintide
Wholesale Cagrilintide supply from SynTide Research featuring configurable vial strengths, direct manufacturing support, global express shipping, and low-MOQ research peptide procurement.
Wholesale pricing$72 - $245
Strength5mg~20mg
MOQ10 vials
Verified supplierSynTide ResearchShips from China · 1,874 orders
Compound information
Cagrilintide
Cagrilintide is a long-acting synthetic amylin analogue developed by Novo Nordisk. It is designed to mimic the biological activity of amylin, a peptide hormone naturally co-secreted with insulin. Cagrilintide has attracted significant attention in obesity and metabolic research because it targets pathways distinct from GLP-1 receptor agonists and is frequently studied both as a standalone compound and in combination with semaglutide.
✓ Long-acting amylin receptor agonist.
✓ Developed by Novo Nordisk.
✓ Investigated in obesity, overweight, appetite regulation, satiety signalling, and metabolic research.
✓ Frequently studied alongside semaglutide in combination therapy research.
ClassSynthetic peptide / long-acting amylin analogue.
TypeEngineered amylin receptor agonist with modifications designed to extend biological activity.
WeightApproximately 3960 Da depending on representation and analytical source.
CAS1415456-99-3
More from seller
More from SynTide Research
Similar listings
